Chronic cough in chronic obstructive pulmonary disease: Time for listening?

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 9, 2013, Pages 902-904

  Burgel, Pierre Régis ^a,b   Wedzicha, Jadwiga A ^c  

^a Institut Cochin   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; ELASTASE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE;

CELL HYPERPLASIA; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER PROGRAM; DEVICES; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; GASTROESOPHAGEAL REFLUX; HUMAN; MUCOUS CELL; MUCUS SECRETION; NEUTROPHIL CHEMOTAXIS; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPUTUM PRODUCTION; SYMPTOMATOLOGY;

COUGH; FEMALE; HUMANS; MALE; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM;

EID: 84877124198     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201302-0332ED     Document Type: Editorial

References (13)

1. Burgel PR. Chronic cough and suptum production: a clinical COPD phenotype? Eur Respir J 2012; 40:4-6.
2. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity: Copenhagen city heart study group. Am J Respir Crit Care Med 1996; 153:1530-1535.
3. Anthonisen NR, Manfreda J, Warren CPW, Herhfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-204.
4. Seemungal TA, Donaldson GC, Paul E.A., Bestall JC, Jeffries DJ, Wedzicha JA Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418-1422.
5. Burgel PR, Nesme-Meyer P, Chanez P., Caillaud D, Carre P, Perez T., Roche N. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009; 135: 975-982.
6. Kim V, Han MK, Vance G.B., Make BJ, Newell JD, Hokanson JE, Hersh CP, Stinson D, Silverman E.K., Criner GJ; COPDGene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPDgene study. Chest 2011; 140:626-633.
7. Hurst JR, Vestbo J, Anzueto A., Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. N Engl J Med 2010; 363:1128-1138.
8. Sumner H, Woodcock A, Kolsum U., Dockry R, Lazaar AL, Singh D, Vestbo J., Smith JA. Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187:943-949.
9. Burgel PR, Nadel JA Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 2008; 32:1068-1081.
10. Nadel JA. Role of neutrophil elastase in hypersecretion during copd exacerbations, and proposed therapies. Chest 2000; 117:386S-389S.
11. Watz H, Waschki B, Boehme C., Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008; 177:743-751.
12. Houghton LA, Smith JA Breaking the sound barrier? Pitfalls and benefits of acoustic cough monitoring. Am J Gastroenterol 2012; 107: 1833-1836.
13. Kessler R, Partridge MR, Miravitlles M, Cazzola M., Vogelmeier C, Leynaud D, Ostinelli J. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 2011; 37: 264-272.